Effects of increasing hydrocortisone to 300mgper day in the treatment of septic shock: A pilot study

Shock

Volumn 46, Issue 5, 2016, Pages 498-505

  Hyvernat, Hervé ^a   Barel, Rémy ^b   Gentilhomme, Anne ^a   Césari Giordani, Jean François ^c   Freche, Annie ^b   Kaidomar, Michel ^c   Goubaux, Bernard ^a   Pradier, Christian ^a   Dellamonica, Jean ^a   Bernardin, Gilles ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Cannes General Hospital   (France)

^c Fréjus General Hospital   (France)

Author keywords

Adverse events; Etomidate; Hydrocortisone; Mortality; Relative adrenal insufficiency; Septic shock; Shock relapse; Vasopressors

Indexed keywords

ETOMIDATE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; HYPERTENSIVE FACTOR; INSULIN; NORADRENALIN; PREDNISOLONE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT;

ABDOMINAL INFECTION; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLEEDING; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INCIDENCE; LARYNX EDEMA; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL INTENSIVE CARE UNIT; MORTALITY; MULTICENTER STUDY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL TIME; TREATMENT DURATION; CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY;

AGED; DOUBLE-BLIND METHOD; ETOMIDATE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84978120412     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000665     Document Type: Article

References (29)

1. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430-1439, 1995.
2. Lefering R, Neugebauer EA: Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 23:1294-1303, 1995.
3. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038-1045, 2000.
4. Annane D, Sébille V, Charpentier C, Bollaert P-E, François B, Korach J-M: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871, 2002.
5. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al.: Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111-124, 2008.
6. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, et al.: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, singlecenter study. Crit Care Med 27:723-732, 1999.
7. Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33:2457-2464, 2005.
8. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645-650, 1998.
9. Arafah BM: Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 91: 3725-3745, 2006.
10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256, 2003.
11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536-555, 2004.
12. McCabe W, Jackson G: Gram negative bacteremia: I. Etiology and ecology. Arch Intern Med 110:845-847, 1962.
13. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963, 1993.
14. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996.
15. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al.: The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 38:1573-1582, 2012.
16. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 41:580-637, 2013.
17. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727-734, 2003.
18. Michalaki M, Margeli T, Tsekouras A, Gogos CH, Vagenakis AG, Kyriazopoulou V: Hypothalamic-pituitary-adrenal axis response to the severity of illness in non-critically ill patients: does relative corticosteroid insufficiency exist? Eur J Endocrinol Eur Fed Endocr Soc 162:341-347, 2010.
19. Morel J, Venet C, Donati Y, Charier D, Liotier J, Frere-Meunier D, Guyomarc'h S, Diconne E, Bertrand JC, Souweine B, et al.: Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 32: 1184-1190, 2006.
20. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167: 512-520, 2003.
21. Sukumaran S, Lepist E-I, DuBois DC, Almon RR, Jusko WJ: Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats. Pharm Res 29:2060-2069, 2012.
22. Ko MS, Nakauchi H, Takahashi N: The dose dependence of glucocorticoidinducible gene expression results from changes in the number of transcriptionally active templates. EMBO J 9:2835-2842, 1990.
23. de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, Papassotiriou J, Elliott PJ, van der Poll T: The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 34:518-522, 2008.
24. Waechter J, Kumar A, Lapinsky SE, Marshall J, Dodek P, Arabi Y, Parrillo JE, Dellinger RP, Garland A: Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med 42:2158-2168, 2014.
25. Park HY, Suh GY, Song J-U, Yoo H, Jo IJ, Shin TG, Lim SY, Woo S, Jeon K: Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study. Crit Care Lond Engl 16:R3, 2012.
26. Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Levy B, Bollaert PE: Risk factors of relative adrenocortical deficiency in ICU patients needing mechanical ventilation. Intensive Care Med 31:388-392, 2005.
27. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C: Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47-56, 2004.
28. Katsenos CS, Antonopoulou AN, Apostolidou EN, Ioakeimidou A, Kalpakou GT, Papanikolaou MN, Pistiki AC, Mpalla MC, Paraschos MD, Patrani MA, et al.: Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response. Crit Care Med 42:1651-1657, 2014.
29. Venkatesh B, Myburgh J, Finfer S, Webb SA, Cohen J, Bellomo R, McArthur C, Joyce CJ, Rajbhandari D, Glass P, et al.: ANZICS CTG investigators. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 15:83-88, 2013.